Shanghai Haohai Biological Technology Co., Ltd.
688366
Rank in Stocks
#9038
Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise... Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise specializing in the research, development, manufacturing, and distribution of advanced biomedical materials. Its operations span Mainland China, the United States, the United Kingdom, and various international markets. The company's extensive product portfolio serves multiple medical fields. For ophthalmology, offerings include intraocular lenses, ophthalmic viscoelastic devices, specialized orthokeratology and phakic refractive lenses, eye drops, injectors, and surgical scalpels. In orthopedics, they provide sodium hyaluronate injections and medical chitosan. Their wound care segment features recombinant human epidermal growth factor, effective in treating a broad spectrum of injuries, including burns, residual wounds, donor site trauma, post-traumatic wounds, and both acute and chronic ulcerations. Anti-adhesion solutions are offered in the form of medical sodium hyaluronate gel and medical chitosan, while hemostatic products include collagen sponges and porcine fibrin sealants. Within medical aesthetics, Shanghai Haohai produces a diverse range of hyaluronic acid (HA) dermal fillers: Matrifill, a first-generation mono-phase injectable gel; Janlane, a second-generation filler engineered for dynamic applications; and Hyalumatrix, a third-generation product designed for precise aesthetic enhancements. This division also supplies radio frequency devices and laser equipment. Beyond its core product offerings, the company actively pursues research and development in biological engineering and pharmaceutical innovations. It also provides related technology transfer and consultation services, alongside engaging in investment and trading activities. Originally established in 2007 as Haohai Limited, the company adopted its current name, Shanghai Haohai Biological Technology Co., Ltd., in 2010 and is headquartered in Shanghai, China.
Share Price
$4.40
Last synced: 2026-11-10
Market Cap
$921.42M
Change (1 day)
-0.48%
Change (1 year)
-39.67%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Shanghai Haohai Biological Technology Co., Ltd. (688366)
Category
Healthcare
Operating Margin for Shanghai Haohai Biological Technology Co., Ltd. (688366)
Operating Margin as of November 2026 TTM: 0.42%
According to Shanghai Haohai Biological Technology Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 0.42%. At the end of 2025 the company had an operating margin of 8.92%.
Operating Margin history for Shanghai Haohai Biological Technology Co., Ltd. from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.42% | -95.29% |
| 2025 | 8.92% | -31.28% |
| 2024 | 12.98% | -7.15% |
| 2023 | 13.98% | 88.66% |
| 2022 | 7.41% | -26.34% |
| 2021 | 10.06% | 67.11% |
| 2020 | 6.02% | -67.00% |
| 2019 | 18.24% | -23.49% |
| 2018 | 23.84% | -12.32% |
| 2017 | 27.19% | -18.50% |
| 2016 | 33.36% | -0.51% |
| 2015 | 33.53% | -7.71% |
| 2014 | 36.33% | 0.36% |
| 2013 | 36.20% | -12.81% |
| 2012 | 41.52% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -8.12% |
US
|
|
| -149.01% | -454.79% |
US
|
|
| 25.57% | -39.12% |
AU
|
|
| 31.23% | -25.64% |
BE
|
|
| 29.35% | -30.12% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Shanghai Haohai Biological Technology Co., Ltd.'s operating margin
What is Shanghai Haohai Biological Technology Co., Ltd.'s operating margin?
Shanghai Haohai Biological Technology Co., Ltd.'s operating margin is 0.42%, as of Nov 2026.
What was Shanghai Haohai Biological Technology Co., Ltd.'s operating margin in 2025?
In 2025, Shanghai Haohai Biological Technology Co., Ltd.'s operating margin was 8.92%, compared with 12.98% in 2024.
How has Shanghai Haohai Biological Technology Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Shanghai Haohai Biological Technology Co., Ltd.'s operating margin was highest in 2023 (13.98%) and lowest in 2020 (6.02%).
How does Shanghai Haohai Biological Technology Co., Ltd.'s operating margin compare with similar companies?
Shanghai Haohai Biological Technology Co., Ltd.'s operating margin (0.42%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.